KnowTheStock
Log inCreate free account

Boston Scientific Corp.

BSX
S&P 500Surgical and Medical Instrument Manufacturing · NEW YORK STOCK EXCHANGE INC.
$43.48last close · market cap 64.12 Billion
Compare with…
71.4SCORE / 100
Our verdictBUYStrong Growth and Improving, Stock Price AttractiveQtr Ending 2026-06-30 · trend positive

Why Buy

Income statement is strong; balance sheet and cash flow are moderate.

Next earnings: 2026-10-28 (BMO), EPS Forecast: $0.76

What is strong
  • Revenue Growth is 13.53%
  • Operating Income Growth is 31.89%
  • Net Income Growth is 46.71%
  • Earnings Per Share (EPS) Growth is 47.02%
  • Net Margin is 17.5%
  • Debt Ratio is 0.2
  • Total Debt to Total Assets Ratio is 0.28
  • Capital Expenditure is Low
  • Net Increase in Cash is Positive
What to watch
  • Current Asset to Current Liability Ratio is 1.24
  • Current Debt to Net Income Ratio is 1.88
  • Cash from Operations Growth is 5.69%

What changed

Score by quarter

Upgraded from Hold to Buy in the Mar 2026 quarter: 68.1 → 75.0 (+6.9). This quarter: -3.5.

4050607080Sep 2022Jun 2026

What the score is made of

Income statement87.6 -0.4
Balance sheet48.3 -8.6
Cash flow58.0 -5.1

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)21.00 Billion13.53 % growth
EPS2.4747.02 % growth
Profit margin17.50 %Profit per $1 of sales
P-E ratio—Not available
Market cap64.12 BillionShares × price
Debt-equity ratio0.51Leverage
Dividend0.00Per share, annual
Next earnings2026-10-28BMO · EPS forecast $0.76
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About Boston Scientific Corp.

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.

CEO
Michael Mahoney
Employees
45,000
Sector
Manufacturing
Exchange
NEW YORK STOCK EXCHANGE INC.
bostonscientific.com

Similar stocks

Loading…